News
1 minute read

MBHB Partner Kevin Noonan Quoted in BioWorld Article Entitled, “PTAB: Tribal Immunity Doesn't Block Restasis Inter Partes Review Proceedings”

Kevin E. Noonan, Ph.D.February 27, 2018

McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. is quoted in a BioWorld article entitled, “PTAB: Tribal immunity doesn’t block Restasis inter partes review proceedings.” In the latest chapter of the continuing saga of six Restasis (cyclosporine) patents, a U.S. Patent Trial and Appeal Board (PTAB) edited out sovereign immunity claims rising from Allergan plc assigning its patents to the Saint Regis Mohawk Tribe and then licensing them back in perpetuity. view the article